TPG Group Holdings (SBS) Advisors’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$20.2M Hold
2,551,794
0.2% 33
2021
Q2
$20.6M Hold
2,551,794
0.15% 34
2021
Q1
$27.4M Hold
2,551,794
0.32% 30
2020
Q4
$30M Hold
2,551,794
0.33% 30
2020
Q3
$30.7M Hold
2,551,794
0.55% 30
2020
Q2
$44.6M Buy
+2,551,794
New +$44.4M 0.79% 26

Other funds holding FUSN

TPG Group Holdings (SBS) Advisors's FUSN Position: Q3 2021 in Review

TPG Group Holdings (SBS) Advisors held its Fusion Pharmaceuticals Inc. Common Shares (FUSN) position steady in Q3 2021 at 2,551,794 shares worth $20.2M. The position accounts for 0.2% of the portfolio, ranked #33.

TPG Group Holdings (SBS) Advisors first reported a position in FUSN in Q2 2020 and has held it in 6 quarters since. The position peaked at $44.6M in Q2 2020. 40 funds tracked by Wall St. Rank hold FUSN as of Q3 2021.

  • TPG Group Holdings (SBS) Advisors held 2,551,794 shares of Fusion Pharmaceuticals Inc. Common Shares worth $20.2M as of Q3 2021.
  • TPG Group Holdings (SBS) Advisors left its Fusion Pharmaceuticals Inc. Common Shares share count unchanged in Q3 2021.
  • Fusion Pharmaceuticals Inc. Common Shares made up 0.2% of TPG Group Holdings (SBS) Advisors's portfolio in Q3 2021, its #33 holding.
  • TPG Group Holdings (SBS) Advisors first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q2 2020 and has held it in 6 quarters since.
  • TPG Group Holdings (SBS) Advisors's Fusion Pharmaceuticals Inc. Common Shares position peaked at $44.6M in Q2 2020.
  • 40 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q3 2021.

Based on TPG Group Holdings (SBS) Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.